Home › NDC Lookup › RxCUI directory › RxCUI 238134

Aspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule — RxCUI 238134

Name: Aspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule (RxCUI 238134)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 238134 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI238134

Official nameAspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asASA 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule

FDA products mapped4

Package NDCs mapped4

Reported Medicaid activity (SDUD)8,077 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin, Butalbital, and Caffeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

This medicine is specifically approved to treat tension headaches — the kind caused by muscle tightness in your head, neck, and shoulders, often with a feeling of stress or pressur...
What exactly is this medicine for? I heard it's for headaches — is it for migraines too?
That's actually something to be careful about. This medicine is not recommended for long-term or repeated use. One of the ingredients — butalbital — is habit-forming and can lead t...
Can I take this every day if my headaches keep coming back?

📖 Read our full Aspirin, Butalbital, and Caffeine guide →

🕸️ Concept Web — How Aspirin 325 MG / butalbital 50 MG / caffeine 40... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Aspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule RxCUI 238134 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Aspirin 1191 IN
- Butalbital 19860 IN
- Caffeine 1886 IN
- Aspirin / butalbital / caffeine 282422 MIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Aspirin / butalbital / caffeine Oral Capsule 374753 SCDF
- Aspirin / butalbital / caffeine Oral Product 1154060 SCDG
- Aspirin / butalbital / caffeine Pill 1154061 SCDG
- Oral Capsule 316965 DF
- Oral Product 1151131 DFG
- Pill 1151133 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Aspirin 325 MG 317300 SCDC
- Butalbital 50 MG 317309 SCDC
- Caffeine 40 MG 317310 SCDC

Showing up to 8 concepts per family — 13 of 13 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Aspirin 325 MG SCDC · 317300
Butalbital 50 MG SCDC · 317309
Caffeine 40 MG SCDC · 317310
Aspirin / butalbital / caffeine Oral Capsule SCDF · 374753
Aspirin / butalbital / caffeine Oral Product SCDG · 1154060
Aspirin / butalbital / caffeine Pill SCDG · 1154061

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 238134 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00527-1552-01	100 CAPSULE in 1 BOTTLE (0527-1552-01)	Butalbital, aspirin, and caffeine	Lannett Company, Inc.	1985-10-11
00781-2270-01	100 CAPSULE in 1 BOTTLE (0781-2270-01)	Butalbital, aspirin, and caffeine	Sandoz Inc	2024-09-03
62135-0433-90	90 CAPSULE in 1 BOTTLE (62135-433-90)	butalbital, aspirin, and caffeine	Chartwell RX, LLC	2022-12-12
69367-0416-01	100 CAPSULE in 1 BOTTLE (69367-416-01)	BUTALBITAL, ASPIRIN, AND CAFFEINE	Westminster Pharmaceuticals, LLC	2025-10-24

Observed labelers: Chartwell RX, LLC (1) · Lannett Company, Inc. (1) · Sandoz Inc (1) · Westminster Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.9750

Range $0.9750–$0.9750 · middle 50% $0.9750–$0.9750 · 4 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.